SURF - Surface Oncology -2.1% after equity sales agreement May, 22 2020 06:56 PM Surface Oncology Inc. Surface Oncology (NASDAQ:SURF) is off 2.1% after hours following its entry into an at-the-market sales agreement with JonesTrading.More news on: Surface Oncology, Inc., Healthcare stocks news, Stocks on the move, Read more ...